Der Methylphenidat-Doppelblindversuch - Indikation und Durchführung

Autor:	Becker K, Bliznakova L, Gerstner S, Schmidt Mh
Rok vydání:	2007
Předmět:	medicine.medical_specialty Treatment system business.industry Methylphenidate Impulsivity medicine.disease Trial Indication Hyperkinetic disorder Double blind Pediatrics Perinatology and Child Health Psychiatric diagnosis Medicine In patient medicine.symptom business Psychiatry medicine.drug
Zdroj:	Klinische Pädiatrie. 219:9-16
ISSN:	1439-3824 0300-8630
DOI:	10.1055/s-2005-836823
Popis:	Hyperkinetic disorders or attention-deficit/hyperactivity disorders (ADHD) are among the psychiatric diagnoses most often encountered in children and adolescents. Symptoms include inattention, hyperactivity and impulsivity. Within the multi-modal treatment system, the therapy with psychostimulants (e. g. methylphenidate) proved to be an effective in patients with ADHD. A double-blind trial is indicated in cases of unclear efficacy of methylphenidate at initial application or if psychostimulants have regularly been applied for more than one year with an leave-out trial delivering unequivocal results. Further it is helpful in verifying potential undesirable side effects and improving patients' compliance.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::16c2ae6862aade613af70ea3f18a0b75 https://doi.org/10.1055/s-2005-836823 Zobrazit plný text záznamu